FDA Inspection 988256 — Lumis Global Pharmaceuticals Co. Ltd.
The FDA completed an inspection of Lumis Global Pharmaceuticals Co. Ltd. on September 28, 2016 in Wuhan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 28, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wuhan (China)